Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders.
about
Management of patients with refractory immune thrombocytopenic purpura.Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.Toxicities of the thrombopoietic growth factorsEltrombopag for the treatment of immune thrombocytopenia.Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.Romiplostim for the treatment of primary immune thrombocytopenia.Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Preliminary nonclinical toxicity, pharmacokinetics, and pharmacodynamics of ALXN4100TPO, a thrombopoietin receptor agonist, in CD2F1 mice.The biology of thrombopoietin and thrombopoietin receptor agonists.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience.Romiplostim in the management of the thrombocytopenic surgical patient.From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.Platelets and cancer: a casual or causal relationship: revisited.Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism.Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis.Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.
P2860
Q33372113-B77A7F13-37EF-4B6F-9DE6-DBAC2D248E86Q33387808-3D8F310B-520E-4F87-927A-439E14767882Q33390645-66CD3BB3-DEDC-4111-A713-07781CBD9234Q33395776-A30B8674-4698-4E23-B039-B62919E8920AQ33396730-5AD2892F-C9EE-4389-9D21-AF01822E2DC1Q33397092-D39E3011-16F0-4604-BC7D-77067663784CQ33400560-11848D32-5460-4CE8-B95D-5AA6AEAE75C6Q33406838-AC3B85BB-AA76-4937-A9D3-372EA7A0FF61Q33406871-A07F1685-C67C-4044-99FE-0277D6FB8573Q33408850-B28985E7-577B-47C7-ACD2-F8920D32B964Q33414386-FE8C952F-203D-4F2A-96C1-2C9B75051E83Q33422342-A23F8999-2EBD-4DE4-98AC-803AE5497C7AQ33423291-38DCE039-3738-41E4-B196-F88B4C5266F1Q33441627-7C63CE16-E7FD-4998-8B76-AF504060BCDAQ34294719-1D7B5B05-FDF6-47F0-9578-F60C9EE150B7Q35110810-14C14A14-68F7-4459-A82D-C3A7CAE16C90Q36116382-B4351EEB-040C-4691-A471-22211273C68BQ38929051-6C7BC150-F417-46D5-B856-BADB6FF8FCA0Q41379688-565E1271-E462-4AAA-867E-5292E78FF212Q52732629-767D5441-7121-4B46-B48A-AFB361703DE7
P2860
Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Thrombopoietin administered du ...... myeloproliferative disorders.
@ast
Thrombopoietin administered du ...... myeloproliferative disorders.
@en
type
label
Thrombopoietin administered du ...... myeloproliferative disorders.
@ast
Thrombopoietin administered du ...... myeloproliferative disorders.
@en
prefLabel
Thrombopoietin administered du ...... myeloproliferative disorders.
@ast
Thrombopoietin administered du ...... myeloproliferative disorders.
@en
P2093
P921
P1476
Thrombopoietin administered du ...... myeloproliferative disorders.
@en
P2093
Larry D Cripe
LoAnn C Peterson
Vonda K Douglas
P304
P356
10.1309/09NP-3DFG-BLM9-E5LE
P407
P577
2002-06-01T00:00:00Z